Clinical Trials · NCT03512236
A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes Mellitus
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Adocia
- Enrollment
- 24
- Start date
- Apr 2018
- Locations
- 1 site, Germany
- Primary endpoint
- CmaxPram